Home > Healthcare & Medical Devices > Compression Therapy Market

Compression Therapy Market Size By Product (Compression Garments {Compression Bandages, Compression Stockings [Compression Class I, Compression Class II, Compression Class III]}, Compression Braces, Compression Tapes, Compression Pumps), By Technology (Static Compression Therapy, Dynamic Compression Therapy), By Application (Varicose Vein Treatment, Deep Vein Thrombosis Treatment, Lymphedema Treatment, Leg Ulcer Treatment), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI2504
  • Published Date: Jan 2021
  • Report Format: PDF

Industry Trends

Compression Therapy Market size exceeded USD 2.3 billion in 2020 and is projected to grow at over 4.5% CAGR between 2021 and 2027. Increasing number of sports injuries and accidents across the globe is propelling the industry growth.

Compression Therapy Market

Get more details on this report - Request Free Sample PDF

Compression therapy is recommended immediately after an injury. Compression pumps and tapes are utilized to improve muscle health, increase blood circulation in the body and prevent coagulation of fluids in tissue space post accidental injuries. Therefore, this therapy is being increasingly adopted to prevent inflammation and swelling following the injury or trauma.

Rise in number of orthopedic procedures is uplifting the adoption rate of compression therapy. Increasing number of vein disorders and rising geriatric population are additional factors driving the compression therapy market demand. Growing awareness among the patients regarding treatment options is leading to increase in number of people opting for compression therapies. Furthermore, increasing technological advancements is augmenting the demand of compression therapy products.

However, the medical compression stocking as a class I medical product is subject to strict requirements. Therefore, compression stocking products are strictly regulated by the FDA. Moreover, a committee researching non-active medical devices (CEN/TC205) and the European Committee for Standardisation (CEN) have set standard for medical compression hosiery. The European standard provides test methods for medical compression hosiery and specifies requirements, including, custom-made hosiery that is used for the treatment of venous and lymphatic diseases of the leg. This standard enables to prescribe medical elastic compression stockings (MECS) with a precise idea of the quality of compression to benefit the patients.  

The ongoing COVID-19 pandemic is an unprecedented public health concern. Hospitalized COVID-19 patients are recommended to have bed rest for a long duration. Thus, immobility in such patients increases the risk of formation of blood clots that can lead to deep vein thrombosis (DVT). In addition, pneumonia is one of the major complications in COVID-19 disease and is also associated with venous thromboembolism (VTE). Therefore, compression therapy is being recommended. However, the disruption related to manufacturing of products and distribution channel has slightly hampered the compression therapy industry.

Growing usage of compression garments will spur the market revenue

Compression garment segment value was more than USD 1,147 million in 2020 owing to the rising geriatric population with lymphatic disorders. Compression garments are being increasingly used by physicians for treatment of lymphedema. They are also majorly used in the treatment of venous leg ulcers, gravitational eczema, varicose veins, venous thromboembolism (VTE) and deep vein thrombosis (DVT). Therefore, the demand for compression garments is increasing significantly. Furthermore, increasing application of compression garments in sports medicine is contributing to the segment growth.

Growing preference for static technology will fuel the market expansion

Compression Therapy Market By Technology

Get more details on this report - Request Free Sample PDF

Static compression therapy market is poised to expand at 4.4% CAGR during the forecast timeframe impelled by greater convenience and user-friendly provisions. The usage of static compression devices is increasing due to greater accessibility of products incorporated with static technology in treatment of edema and sports-related injuries to ease pain and pressure. Furthermore, static devices are extensively used due to their easy application and removal as compared to other products.

Increasing adoption of compression therapy in varicose vein treatment

Varicose vein treatment segment is anticipated to witness growth of 4.2% through 2027 led by the high prevalence of varicose vein condition across the globe. According to a recently published article, varicose veins condition affects up to 3 in 10 adults. Moreover, varicose veins condition is more prevalent in women along with geriatric population and affects approximately 22 million women between the age of 40 to 80 years. Patients having varicose veins condition are recommended to undergo six months compression therapy and graduated compression hosiery is being widely used as a first line treatment for varicose vein condition.

Increasing healthcare expenditure in North America will boost the regional market growth

Global Compression Therapy Market By Region

Get more details on this report - Request Free Sample PDF

U.S. dominated the North America compression therapy market and held largest revenue share of 90% in 2020 due to the high prevalence of venous diseases such as venous leg ulcer and lymphedema in the country, new product launches and high investment in research and development. According to an article by the National Center for Biotechnology and Information (NCBI), approximately 6-7 million people in the U.S. have an existing diagnosis of advanced venous disease. In addition, presence of several established pharmaceutical companies that are consistently focusing on extensive commercialization and enhancing their geographical reach is contributing to the market growth in the region.

Several strategic initiatives implemented by major industry players will boost the market growth

Some of the major players operating in the compression therapy industry are 3M Company, BSN Medical, Cardinal Health, Inc., Convatec Inc., DJO Global, Inc., Medi Gmbh & Co. KG, Paul Hartmann AG, Sigvaris, and Tactile Medical. Several strategies are being undertaken such as several strategic product launches, mergers, acquisitions, collaborations, and partnerships to maintain a competitive edge over their peers. These players are also engaged in making investments that enables these players in capturing maximum revenue share.

The compression therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product

  • Compression Garments
    • Compression Bandages
    • Compression Stockings
      • Compression Class I
      • Compression Class II
      • Compression Class III
    • Others
  • Compression Braces
  • Compression Tapes
  • Compression Pumps

Market, By Technology

  • Static Compression Therapy
  • Dynamic Compression Therapy

Market, By Application

  • Varicose Vein Treatment
  • Deep Vein Thrombosis Treatment
  • Lymphedema Treatment
  • Leg Ulcer Treatment
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The market size for compression therapies was over USD 2.3 billion in 2020 and register more than 4.5% CAGR up to 2027 with increasing cases of accidents and sports injuries.

The static compression therapy segment size is anticipated to record over 4.4% CAGR between 2021-2027 owing to better convenience and user-friendliness of the products.

The industry share from varicose treatment segment will expand at around 4.2% CAGR through 2027 with the high prevalence of the condition among women and geriatric population.

The U.S. accounted for 90% share of the North America market in 2020 due to high R&D spending and consistent prevalence of venous leg ulcer, lymphedema, and other disorders.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2020
  • Companies covered: 15
  • Tables & Figures: 302
  • Countries covered: 18
  • Pages: 200

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount